Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucia Batzu

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Brain Communications|October 2, 2024
Visual mismatch negativity in Parkinson's psychosis and potential for testing treatment mechanismsMiriam Vignando, Dominic Ffytche, Ndabezinhle Mazibuko, et al.
Frontiers in Neurology|June 12, 2023
Chaudhuri's Dashboard of Vitals in Parkinson's syndrome: an unmet need underpinned by real life clinical testsMubasher A Qamar, Silvia Rota, Lucia Batzu, et al.
Molecular Neurodegeneration|October 25, 2024
Repetitive transcranial magnetic stimulation alleviates motor impairment in Parkinson's disease: association with peripheral inflammatory regulatory T-cells and SYT6Fen Xie, Bibiao Shen, Yuqi Luo, et al.
Journal of Parkinson'S Disease|September 27, 2024
Validation Study of the Parkinson's Disease Stigma Questionnaire (PDStigmaQuest)Vasilija Stopic, Stefanie T Jost, Julius Haupt, et al.
NPJ Parkinson'S Disease|January 2, 2025
Plasma fibronectin is a prognostic biomarker of disability in Parkinson's disease: a prospective, multicenter cohort studyShuzhen Zhu, Hualin Li, Zifeng Huang, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 23, 2025
Effects of a Four-Strain Probiotic on Gut Microbiota, Inflammation, and Symptoms in Parkinson's Disease: A Randomized Clinical TrialValentina Leta, Pavlos Zinzalias, Lucia Batzu, et al.
Lancet (London, England)|February 7, 2025
Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trialNirosen Vijiaratnam, Christine Girges, Grace Auld, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Brain Communications|October 2, 2024
Visual mismatch negativity in Parkinson's psychosis and potential for testing treatment mechanismsMiriam Vignando, Dominic Ffytche, Ndabezinhle Mazibuko, et al.
Frontiers in Neurology|June 12, 2023
Chaudhuri's Dashboard of Vitals in Parkinson's syndrome: an unmet need underpinned by real life clinical testsMubasher A Qamar, Silvia Rota, Lucia Batzu, et al.
Molecular Neurodegeneration|October 25, 2024
Repetitive transcranial magnetic stimulation alleviates motor impairment in Parkinson's disease: association with peripheral inflammatory regulatory T-cells and SYT6Fen Xie, Bibiao Shen, Yuqi Luo, et al.
Journal of Parkinson'S Disease|September 27, 2024
Validation Study of the Parkinson's Disease Stigma Questionnaire (PDStigmaQuest)Vasilija Stopic, Stefanie T Jost, Julius Haupt, et al.
NPJ Parkinson'S Disease|January 2, 2025
Plasma fibronectin is a prognostic biomarker of disability in Parkinson's disease: a prospective, multicenter cohort studyShuzhen Zhu, Hualin Li, Zifeng Huang, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 23, 2025
Effects of a Four-Strain Probiotic on Gut Microbiota, Inflammation, and Symptoms in Parkinson's Disease: A Randomized Clinical TrialValentina Leta, Pavlos Zinzalias, Lucia Batzu, et al.
Lancet (London, England)|February 7, 2025
Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trialNirosen Vijiaratnam, Christine Girges, Grace Auld, et al.
Pageof 5